CM
SEM

Crestline Management’s Select Medical SEM Stock Holding History

Crestline Management’s Portfolio SEM Stock Details SEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-66,283
Closed -$482K – 181
2016
Q3 		$482K Buy
+66,283
New +$421K 0.06% 147

Other funds holding SEM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Crestline Management's SEM Position: Q4 2016 in Review

Crestline Management sold out of Select Medical (SEM) in Q4 2016, closing a stake of 66,283 shares — an estimated $482K sold.

Crestline Management first reported a position in SEM in Q3 2016 and held it in 1 quarter. The position peaked at $482K in Q3 2016. 156 funds tracked by Wall St. Rank hold SEM as of Q4 2016.

  • Crestline Management reported no remaining Select Medical position as of Q4 2016 after selling out during the quarter.
  • Crestline Management sold 66,283 Select Medical shares in Q4 2016, an estimated $482K.
  • Crestline Management first reported a position in Select Medical in Q3 2016 and held it in 1 quarter.
  • Crestline Management's Select Medical position peaked at $482K in Q3 2016.
  • 156 funds tracked by Wall St. Rank held Select Medical as of Q4 2016.

Based on Crestline Management's 13F filing for Q4 2016, filed 14 Feb 2017.